key: cord-0260584-agq6bjgf
authors: Samsudin, Firdaus; Raghuvamsi, Palur; Petruk, Ganna; Puthia, Manoj; Petrlova, Jitka; MacAry, Paul; Anand, Ganesh S.; Schmidtchen, Artur; Bond, Peter J.
title: SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
date: 2021-11-06
journal: bioRxiv
DOI: 10.1101/2021.10.29.466401
sha: 143c28c1e35beab56b0e3e7067b69c82008173db
doc_id: 260584
cord_uid: agq6bjgf

Accumulating evidence indicates a potential role for bacterial lipopolysaccharide (LPS) in the overactivation of the immune response during SARS-CoV-2 infection. LPS is recognised by Toll-like receptor 4 (TLR4) in innate immunity. Here, we showed that LPS binds to multiple hydrophobic pockets spanning both the S1 and S2 subunits of the SARS-CoV-2 spike (S) protein. LPS binds to the S2 pocket with a lower affinity compared to S1, suggesting its possible role as an intermediate in the TLR4 cascade. Congruently, nuclear factor-kappa B (NF-κB) activation in vitro is strongly boosted by S2. In vivo, however, a boosting effect is observed for both S1 and S2, with the former potentially facilitated by proteolysis. Collectively, our study suggests the S protein may act as a delivery system for LPS in host innate immune pathways. The LPS binding pockets are highly conserved across different SARS-CoV-2 variants and therefore represent potential therapeutic targets.

demonstrated significantly elevated levels of bacterial LPS. 17 Non-survivor COVID-19 1 patients also presented increased systemic level of LPS and soluble CD14 during 2 hospitalisation compared to survivors, indicating a link between elevated LPS level and 3

death. 18 Using a combination of in vitro and in vivo experiments, we previously showed that 4

SARS-CoV-2 spike (S) protein can bind to LPS with a similar affinity to CD14, and boosts 5 proinflammatory activity, 19 thus providing a potential link between high-risk COVID-19 6 patients and observed symptoms like ARDS and sepsis. Nevertheless, the detailed molecular 7 mechanisms underlying the interactions between the S protein and LPS and how these 8

interactions result in an increased inflammatory response are still unclear. 9

The S protein is a class 1 viral fusion protein trimer that protrudes from the surface of 10 SARS-CoV-2. 20,21 The protein is made of two subunits: the S1 subunit that is involved in 11 receptor binding, and the S2 subunit that facilitates membrane fusion. Proteolysis at the S1/S2 12 cleavage site by host cell proteases such as furin, 22 followed by a second proteolytic cleavage 13 on the S2' site, results in shedding of the S1 subunit and a conformational transition of the S2 14 subunit into the post-fusion state, 23 which leads to fusion with the host cell membrane and 15

initiation of infection. The S1 subunit may be further divided into subdomains such as the N-16

terminal domain (NTD) and the receptor binding domain (RBD), while the S2 subunit is 17

composed of the fusion peptide, heptad repeats, central helix, connector domain and the 18 transmembrane domain. The RBD defines the functional conformation of the S protein, 19

whereby the "open" conformation is characterised by at least one RBD in the "up" 20 conformation which is able to bind to the ACE2 receptor, while the "closed" conformation is 21 characterised by all three RBDs adopting the "down" conformation therefore making them 22

inaccessible to ACE2. The structure of the prefusion S protein ectodomain (ECD) has been 23

resolved in both open and closed conformations using cryo-electron microscopy (cryo-24 EM) 21,23,24 . Importantly, accumulating structural evidence from cryo-EM has revealed that S 25 protein is able to bind various non-polar molecules such as linoleic acid 25 , polysorbate 26 and 26 haem metabolites 27 by employing hydrophobic cryptic pockets in the NTD and RBD. A 27 neutron reflectometry study showed the SARS-CoV-2 S protein significantly degrades lipid 28 bilayers by extracting lipids from the membrane, suggesting a strong association of the protein 29

with lipid molecules 28 . Using computational docking and molecular dynamics (MD) 30

simulations, we predicted that LPS may bind to an inter-protomeric groove nearby the S1/S2 31 cleavage site. 19 Similar to the pockets found on the NTD and RBD, this groove has a group of 32 partially exposed hydrophobic residues that could accommodate the LPS lipid tails, primarily 33

found on the S2 subunit (hence designated as the "S2 pocket"). It is not known, however, if 34

LPS can bind to the NTD and RBD pockets.

Structural characterization of LPS binding to proteins using methods such as cryo-EM 36 and X-ray crystallography is challenging due to its heterogenous nature. In this study, we used 37 hydrogen-deuterium exchange mass spectrometry (HDXMS) to verify LPS binding to the S2 38 pocket of the S protein, while uncovering binding to the NTD and RBD pockets. This was 39 supported by native gel electrophoresis showing LPS interaction with both S1 and S2 subunits 40

independently. Calculation of potentials of mean force (PMFs) within a molecular dynamics 41

(MD) simulation framework, supported by microscale thermophoresis (MST) binding 42

experiments, indicate that LPS binds with strong affinities to the RBD and NTD pockets on 43 the S1 subunit, while the S2 pocket represents a weaker binding site compared to the LPS 44 receptor, CD14, suggesting its potential role as an intermediate in the LPS receptor transfer 1 cascade. 29 Furthermore, monocytic THP-1 cell assays show boosting of nuclear factor-kappa 2 B (NF-κB) activation by LPS in the presence of the S2 subunit, but not with the S1 subunit. 3

Finally, NF-κB reporter mice experiments show enhanced inflammatory response with both 4 S1 and S2 subunits of the S protein. Collectively, a molecular mechanism of how the SARS-5

CoV-2 S protein augments LPS-mediated hyperinflammation emerges, whereby the S protein 6

acts as an additional LPS delivery system to the CD14 receptor, and eventually to the 7 TLR4:MD-2 complex. 8 9

Results 10

Structural detection of lipid A/LPS binding to SARS-CoV-2 spike protein 11

To map binding and allosteric effects of lipid A or LPS on S protein, we performed HDXMS 12 on free S protein and S protein saturated with either lipid molecules. Our HDXMS analysis 13

identified pepsin fragment peptides (217 peptides in free S protein state) covering ~82% of the 14 S protein sequence in the free and bound states ( Figure S1 ). HDXMS provides a readout of 15 solvent accessibility and hydrogen-bonding propensity at a peptide level resolution, and may 16 be used to capture both orthosteric and allosteric effects of ligand/partner protein binding upon 17 protein structure. 30-33 HDXMS has previously been used to characterize large-scale dynamics 18

of the S protein in the presence of the ACE2 receptor 34 and an alternative open trimer 19

conformation of the ECD. 35 Comparative deuterium exchange analysis was performed using 20 deuterium exchange difference plots, wherein the difference in deuterons exchanged for each 21

pepsin proteolyzed peptide at different deuterium labelling times (t =1, 10, and 100 min) 22

between bound and free S protein states were plotted. A difference in deuterium exchange of 23 ± 0.5 Da was chosen as the significance threshold 36 to identify lipid A/LPS binding induced 24 effects on the S protein.

Deuterium exchange difference plots mapped onto the structure of S protein revealed 26 multiple non-contiguous loci spanning multiple domains -RBD, NTD and S2 domain ( Figure  27 1B-D, S2 and S3) -that were deuterium exchange protected in the lipid A or LPS bound states. 28

Interestingly, protected peptides spanning the RBD (residues 331-360, 496-512) and NTD 29

(residues 92-106, 119-129, 180-191) highlight cavities, optimal for binding lipid A ( Figure 1B , 30 1C(i) and 1C(ii)). These lipid binding cavities were reported in two separate cryo-EM studies 31

wherein densities corresponding to a polysorbate 80 detergent or lipid tails were identified 25,26 . 32

Antiparallel β-strands form a sandwich structure, a convenient binding site for aliphatic tails 33 of lipid A. In the case of the RBD, the lipid A binding cavity consists of a short α-helical region 34 called the "gating helix" along with antiparallel β-strands. Further, several peptides spanning 35

the NTD (residues 291-298), subdomain (SD, residues 538-565), S2 subunit (residues 835-36 859), and HR1 domain (residues 947-978) show protection from deuterium exchange in the 37 presence of lipid A ( Figure 1C (iii)). These peptides are at the inter-protomer interface of the 38 trimeric S protein, forming a hydrophobic cavity which coincides with our previously 39 computationally predicted LPS interaction site. 19 Interestingly, this region is located close to 40 the functionally significant S1/S2 cleavage site which plays a critical role in viral entry ( Figure  41 1D). 42

Overall, S protein:lipid A and S protein:LPS bound states show comparable deuterium 43 exchange profiles, and similar peptides were observed to bind lipid A and LPS ( Figure 1B -D, 44 S2 and S3). Increases in deuterium exchange were observed in peptides spanning NTD and 1 RBD (residues 72-88, 94-103, 145-165, 178-191, 356-375 and 400-421) at 1 min deuterium  2 labelling time in the presence of LPS ( Figure S3A , S3B(i) and S3B(ii)). The increases in 3 deuterium exchange indicate the local destabilization of binding cavities at NTD to 4 accommodate the considerably larger and more heterogeneous LPS molecule compared to lipid 5

A. Peptides spanning the RBD (peptide 331-346, 496-512) and S2 cavity (peptide 835-859, 6 946-978) show protection at 1 and 10 min labelling times ( Figure S3B (ii)-S3B(iii)) similar to 7 the lipid A bound state. Peptide 1178-1187 spanning the HR2 region also showed protection 8

in the presence of both lipid A and LPS at 1 and 10 min labelling times, which is corroborated 9 by recent computational predictions and an NMR study 37,38 suggesting the potential for binding 10 of hydrophobic molecules such as lipids. An interesting similarity between lipid A and LPS 11 bound S protein is seen with the protection from deuterium exchange at the receptor binding 12 motif (RBM) of the RBD, a crucial component involved in ACE2 receptor interactions. 13

Interestingly, at longer labelling times (t = 100 min), increases in deuterium exchange 14

were observed across multiple regions on the S protein, especially at the NTD, RBD and S2 15

binding sites in the presence of lipid A or LPS ( Figure S2 and Figure S3 ). protomer contacts of the S protein ( Figure S4 ), potentially exacerbated by accommodation of 26 more than one lipid molecule, also supported by our simulations below. 27

Overall, the deuterium exchange profile of the S protein:lipid A state serves as a 28 reference to differentiate between interactions of the aliphatic lipid tails versus the long 29 polysaccharide chain with the S protein. Comparing the two suggests that deuterium exchange 30 readout from S protein bound states predominantly reports on aliphatic lipid tail interactions 31 with S protein, at three dominant sites spanning the NTD / RBD pockets in S1 and a separate 32 S2 site.

Analysis of binding of SARS-CoV-2 S1 and S2 to LPS and lipid A 35

To study the binding between LPS or lipid A with the S protein subunits S1 and S2, we used 36 BN-PAGE followed by western botting, using specific antibodies against His-tag. We have 37

previously shown that binding of E. coli LPS to SARS-CoV-2 S protein affects the migration 38 of the protein on BN-PAGE. 19 In agreement with our previous results, S protein alone migrated 39 at a molecular mass of around 480 kDa (Figure 2A , left panel). 19 The S1 and S2 subunits 40 migrated at molecular masses of around 242 and 146 kDa, respectively. The S1 and S2 band 41

intensity decreased with increasing doses of LPS which indicates an interaction between the 42 proteins and LPS, as illustrated by the histograms (Figure 2A , right panel). We observed that 43 the change in migration was more marked for S2 when compared with S1. Next, we evaluated 44 the binding of S1 and S2 to lipid A. S protein was included for comparison ( Figure 2B ). We 1 found that both subunits bind to lipid A, as shown by a decrease of bands at 242 and 146 kDa, 2 for S1 and S2, respectively, and concomitantly a formation of high molecular weight material 3 not entering the gel was observed. Interestingly, lipid A binding to S2 was already significant 4

at 100 µg/ml of lipid A. SDS-PAGE analysis of S, S1 and S2 under denaturing conditions 5

showed homogenous bands ( Figure S5A ). Using native conditions however, BN-PAGE 6

analysis showed that the preparations of S, S1 and S2 all contained several forms of higher 7 molecular weights when compared with the monomer. This is not unexpected, particularly for 8 the S2 subunit which has been reported to assume a post-fusion trimer structure that is more 9

stable and rigid, both in the absence or the presence of ACE2. 23 To explore whether the 10 interaction between S2 and LPS was dependent on the pre-and/or post-fusion conformation of 11 S2 we therefore used a mutant-S2 subunit having targeted amino acids substituted with proline 12 residues (F817P, A892P, A899P, A942P, K986P, V987P) in order to prevent fusogenic 13 structural rearrangements in S2. 40 After incubation with increasing doses of LPS, the proline-14

substituted S2 protein was analysed on BN-PAGE ( Figure S5B ) followed by western blot 15 analysis. As above with S2, apart from the monomer at around 146 kDa, the results showed 16

bands of different molecular weights. It was, however, observed that the monomer band at 146 17 kDa was more defined than seen with the wild type S2 subunit ( Figure 2A ). Moreover, in the 18 samples with LPS, almost no visible S2 protein was seen in the gel, not even at lower 19

concentrations, suggesting a more pronounced interaction between LPS and S2 in its pre-fusion 20

conformation. In addition, we did not observe any bands at higher molecular weights that were 21 stacked on top of the well, as previously detected for the S2:lipid A mixture ( Figure 2B ), 22

suggesting the formation of larger aggregates incapable of penetrating the gel during 23 electrophoresis.

Spike protein binding sites have different affinities for LPS 26

Our HDXMS data have identified at least three binding sites for LPS and lipid A on the S 27 protein: the NTD, RBD and S2 pockets. This indicates that both S1 and S2 subunits have 28

binding sites for LPS, which was verified experimentally using BN-PAGE. Our previous study 29

showed that LPS binding to the S2 pocket involved residues from both S1 and S2 subunits. 19 30

To determine whether LPS binding to this site requires both S1 and S2, we performed MD 31 simulations of LPS bound to this site without the S1 component. MD simulations provide a 32 means to analyse the dynamics of such ligand-protein interactions at atomic resolution. 33

Interestingly, LPS remained stably bound to the isolated S2 domain, as assessed by 34 measurement of the root mean square deviation (RMSD) of the lipid with respect to its initial 35 conformation, which remained low and comparable to the RMSD observed during simulations 36 of the whole S ECD ( Figure S6 ). This suggests that the key residues for LPS binding in this 37 pocket are those found on S2, and residues from S1 may be less crucial for binding. For 38 comparison, simulations of LPS bound to this binding site in a truncated system containing just 39 the S1 subunit revealed LPS detachment from the binding site, and consequently, significantly 40

higher RMSD values. This indicates that LPS binding to the S1 subunit observed in our BN-41 PAGE experiment does not involve the S2 pocket, but rather involves the pockets in the NTD 42 and RBD only. Cryo-EM studies revealed that the hydrophobic pockets within the NTD and RBD can 1 accommodate the binding of small hydrophobic molecules, such as polysorbate, linoleic acid 2 and haem metabolites. 25,26,39 As the lipid A component of LPS contains multiple acyl tails and 3 a large diglucosamine headgroup, how it binds to the NTD and RBD pockets remains unclear. 4

To characterize the dynamics of LPS binding to these domains, we performed unbiased MD 5

simulations whereby a hexa-acylated E. coli lipid A molecule was placed nearby the NTD and 6

RBD facing the hydrophobic pockets. We found that in all simulations, the lipid tails 7

spontaneously inserted into the binding sites. The hydrophobic pockets expanded to 8 accommodate the lipid tails, especially on the RBD in which the pocket volume became 9

significantly larger in simulations upon complexation with lipid A ( Figure S7 ). We calculated 10 the solvent accessible surface area (SASA) of individual lipid tails to determine how many of 11 them can bind to the pocket simultaneously. The NTD pocket can accommodate up to five 12 tails, whereas the flexible RBD site can accommodate as many as all six lipid tails of lipid A 13

( Figure 3A -3B) upon pocket expansion. Congruently, we found that the binding of lipid A to 14

RBD results in a lower percentage of its lipid tail atoms being exposed to solvent compared to 15

binding to NTD, suggesting the potential for stronger binding ( Figure 3C and 3D). Structural 16 clustering analysis suggests that NTD can accommodate a limited length of each of the lipid 17

tails (approximately 5 carbon atoms distal from the glucosamine units), whereas the RBD can 18

accommodate the entirety of the tails ( Figure 3E -3F).

While our unbiased MD simulations further validate LPS binding to these pockets on 20 the S1 and S2 subunits, the binding affinity to each pocket remains unknown. To estimate lipid 21

A affinities to all three identified binding sites on the S protein, we performed potential of mean 22

force (PMF) calculations. Steered MD simulations were run to extract lipid A from each site 23

and into bulk solvent, from which snapshots were selected as windows for umbrella sampling 24

(details in Methods). Adequate sampling along the reaction coordinate was achieved, as 25 indicated by the excellent histogram overlap and convergence of each PMF profile ( Figure S8 ).

The PMFs suggest that lipid A binds most strongly to the RBD pocket, with a free energy 27 estimated to be around 125 kJ mol -1 ( Figure 4A ). Intriguingly, this is comparable to the value 28 of 135 ± 5 kJ mol -1 previously calculated for CD14 29 , which serves as a conduit for LPS in the 29 TLR4 pathway. This result is thus consistent with our previous microscale thermophoresis 30 experiment showing similar KD values for LPS interaction with S protein and CD14. 19 The 31

NTD pocket exhibited a slightly lower binding affinity with an estimated free energy of 32 approximately 95 kJ mol -1 ( Figure 4B ). This agrees with our unbiased simulations showing 33 that lipid A binding to NTD involves a reduced portion of the lipid tails, compared to the RBD 34 which can accommodate the full length of the tails and as many as all six tails simultaneously 35

( Figure 3E and 3F). 36

Finally, our PMF calculations for the S2 pocket yielded a free energy value of around 37 50 kJ mol -1 ( Figure 4C ) which hence represents the weakest lipid A binding pocket on the S 38 protein. Our previous pocket mapping study using benzene probes on the S protein indicated 39 that the S2 pocket is a deep surface indent, rather than a quintessential binding pocket like the 40 ones on NTD and RBD 37 , hinting at a lower protection of the lipid tails from solvent, and hence 41 weaker affinity. We calculated the percentage of lipid tail exposure to water in each of the 42 umbrella sampling windows for all three PMF calculations. Indeed, the S2 pocket displayed a 43 less dramatic increase in solvent exposure during lipid dissociation, with 60-70% lipid tails 44 buried when bound compared to 80% when in bulk solvent, in contrast with the RBD pocket 1 which is associated with a steep increase from less than 40% to 80% upon unbinding ( Figure  2 S9). While the binding affinity to the S2 pocket may seem much weaker than the NTD and 3

RBD pockets, the free energy value is still significant, indicating that a free lipid A molecule 4

would favourably bind to this site. However, in the presence of proteins with higher affinities 5

to lipid A, such as CD14, the lipid A molecule bound equilibrium would presumably shift, 6

suggesting that the S2 pocket could play a role as an intermediary in the TLR4 cascade. 7

To verify the predicted affinities of LPS to the different S protein binding pockets, we 8 performed microscale thermophoresis (MST) and determined the dissociation constant (KD) 9

values for LPS binding to the S1 and S2 subunits independently ( Figure 4D ). The KD obtained 10 for the S1 subunit was in the same range as for the S protein, 50.0 ± 20.0 and 46.7 ± 19.7 nM, 11

respectively. The low KD value for the S1 subunit is in good agreement with our PMF 12

calculations showing the presence of high-affinity binding pockets for lipid A in the NTD and 13

RBD. Conversely, the KD obtained for the S2 subunit was 3.6 ± 1.6 µM. This higher KD value 14

supports the lower free energy of dissociation determined by our PMF calculations, further 15

corroborating a weaker-affinity binding site for LPS on the S2 subunit. 16

Intriguingly, our BN-PAGE experiment showed that LPS alters the migration of S2 17 more prominently compared to S1 (Figure 3 ), particularly for the prefusion stabilized S2 18 construct ( Figure S5B ), suggesting a more pronounced interaction with S2. We note that the 19 concentration of LPS used in all our BN-PAGE experiments is well above the KD values 20 determined by MST (10-50 µM). Due to the large size of the inter-protomeric gap forming the 21 S2 pocket and the partially exposed lipid tails of bound LPS, we hypothesized that more than 22

one LPS molecule could occupy the binding site potentially through lipid-lipid interactions, 23

which would explain the marked changes in migration pattern of the S2 subunit in the presence 24

of LPS. To test this hypothesis, we performed an unbiased MD simulation with three additional 25 lipid A molecules placed outside of the groove, whose centers of mass were at least 2 nm from 26 the bound lipid A. We found that within 300 ns, all three lipid A molecules spontaneously 27 entered the S2 pocket and formed a small lipid A aggregate within the binding site with the 28 already bound lipid A molecule ( Figure S10 ). This aggregate remained stably bound to the S2 29 pocket for the remainder of the 500 ns simulation. This suggests that the S2 pocket could act 30 as a pool for small LPS aggregates, and may therefore be able to serve a role in forward transfer 31 along the TLR4 relay. 32 33

We have previously shown that S protein, when combined with ultralow-threshold levels of 35 LPS, boosts nuclear factor-kappa B (NF-kB) activation in monocytic THP-1 cells and 36 proinflammatory cytokine release in human blood. 19 Since both S1 and S2 subunits bind to 37 LPS, we next explored whether these S protein subunits could enhance proinflammatory 38 responses as well. Therefore, we first incubated THP-1 cells with increasing concentrations of 39 LPS (0-1 ng/ml) and a constant amount (5 nM) of S1 or S2. After 20 h, the levels of NF-kB 40

were measured. The results reported in Figure 5A (left panel), show that the S2 subunit alone 41

stimulates NF-kB production. This observation prompted us to investigate whether the 42 preparation could be contaminated by LPS, as has been reported for various commercial S 43 protein preparations. 41 Indeed, we found that the endotoxin levels were 3.5 and 1401.1 fg/µg 1 in S1 and S2, respectively. It is of note that the level of LPS observed in the S2 preparation 2

does not yield any detectable proinflammatory response in THP-1 cells per se; 1 and 10 pg/ml 3 LPS yielded no NF-kB activation (n=3, p=0.9982 and 0.9998, respectively). Nevertheless, 4

taking this confounding endogenous LPS contamination into account, the results demonstrate 5 that exogenously added LPS at ultra-low levels indeed induce a boosting of NF-kB. 6 Surprisingly, no boosting effect was observed for the S1 subunit, either alone or in combination 7

with LPS. Nevertheless, the proinflammatory effect of LPS was not even supressed by the 8 addition of the S1 subunit. It is worth noting that no tested condition was cytotoxic, excluding 9

low cell response to stimuli due to death ( Figure 5A , right panel). To verify that S2 had a higher 10 proinflammatory effect because of LPS contamination, we performed the experiments on THP-11 1 cells in the presence of polymyxin B, a well-established neutralizer of LPS. 42 From the result 12 reported in Figure 5B , it is seen that the addition of polymyxin B suppresses the NF-kB 13 activation, both due to S2 alone and to S2 mixed with LPS, indicating an LPS-mediated effect 14 by the S2 preparation. As expected, no visible alteration in NF-kB levels was observed in the 15 case of THP-1 cells treated with the S1 subunit alone, or with LPS and/or polymyxin B. The 16

results with the S2 preparation prompted us to investigate the behaviour of the stabilised 17

prefusion construct, i.e. S2 P-mutant. This variant contained 5.7 fg of LPS /µg of protein, which 18 was comparable to the levels observed in S protein and S1 subunit. Correspondingly, the 19 prefusion stabilized S2 construct showed less intrinsic proinflammatory activity per se, but 20 retained a significant ability to boost the responses to ultra-low levels of LPS ( Figure S11 ). 21

Hence, the stabilized S2 protein retained the inflammation boosting activity previously 22 demonstrated for the whole S protein. 19 23

Using mice reporting NF-κB activation, we previously showed that neither 2 µg LPS 24 nor 5 µg SARS-CoV-2 S protein alone induced a significant proinflammatory response when 25 injected subcutaneously. However, when combined together, a marked boosting of 26 inflammation was observed. 19 Using a similar setup, we decided to investigate the responses 27

to S1 and S2, and effects on LPS. S1 alone did not yield any measurable NF-κB activation 28

( Figure 6A ). S1 when combined with 2 µg LPS resulted in a significant proinflammatory 29 response. S2 alone yielded a proinflammatory response per se, which was not unexpected given 30 the detected LPS content in this preparation ( Figure S12 ). Like the in vitro results above ( Figure  31 5), addition of polymyxin B to the S2 preparation reduced the proinflammatory response, 32

indicating that LPS was causing the NF-κB activation ( Figure S12 ). Analogously to the in vitro 33 data, the prefusion stabilized S2 form showed a significant boosting effect on LPS responses 34 ( Figure 6B ). Taken together, the results showed that S1 has a boosting effect on LPS-induced 35

inflammation. Indirectly, the results also showed that S2's inherent proinflammatory effect is 36 due to minute LPS-contaminants, resulting in a boosted NF-κB response to the combination. 37

The proline-stabilized S2 construct, which contained less contaminating LPS, exhibited a low 38

pro-inflammatory activity alone, but significantly boosted the response to 2 µg LPS. 39

It is intriguing that S1 displays a boosting effect on LPS-induced inflammation in vivo 40

but not in vitro, suggesting additional mechanisms in the former. We hypothesize that one 41 potential reason for this in vitro-in vivo difference is the interactions with proteases secreted in 42 the tissue during inflammation, such as the neutrophil elastase (NE), that could modify the 43 structure of the S1 subunit and alter its affinity to LPS. To test this hypothesis, we incubated 1 THP-1 cells with the digested and undigested S1 subunit in the absence and presence of LPS. 2

Indeed, S1 mixed with LPS and then digested with NE for 15 minutes was able to increase NF-3

kB production compared to the mixtures without NE and pre-digested S1 ( Figure S13 ). This 4 supports our hypothesis that LPS binding to the high affinity sites in S1 in vivo is compromised 5 by proteolysis during inflammation resulting in an onward transfer to LPS receptors. The 6

proteolytic sites of these enzymes and how they weaken LPS binding, however, would require 7 further studies. 8 9

Discussion 10

There is growing evidence that bacterial LPS plays a central role in severe COVID-19 11

complications 15-19,43,44 . Overstimulation of the TLR4 pathway by LPS triggers a 12 hyperinflammatory state that can lead to sepsis and ARDS. In this study, we showed that LPS 13 binds to SARS-CoV-2 S protein at various sites resulting in amplified proinflammatory 14

responses. In the TLR4 pathway, LPS is transferred from the outer membrane of Gram-15

negative bacteria through a series of receptor proteins to its terminal receptor site, the 16 TLR4:MD-2 complex, which initiates downstream signal activation 45-47 . An affinity gradient 17

exists between LPS and these receptors to favour a one-way transfer that culminates at 18 TLR4:MD-2 29 . Here, we propose how the S protein fits into the LPS transfer cascade ( Figure  19 7). S protein disaggregates LPS micelles 19,28 via high affinity binding to the S1 pockets on the 20 NTD and RBD ("high-affinity, low-capacity" binding sites), which are positioned at the 21 outermost part of the S protein and the virus. The NTD and RBD pockets have similar LPS 22

binding affinities to the CD14 receptor, 29 which in vitro results in unfavourable onward 23

transfer. However, the presence of proteases secreted during inflammation in vivo could 24

compromise LPS binding resulting in LPS dissociation and transfer to other receptors. 25

Additionally, the S1 pockets can also bind to various endogenous hydrophobic molecules such 26 as lipids and metabolites, 25-27 which could displace LPS and promote subsequent transfer 27 events. Conversely, the S2 site has a weaker binding affinity and is considerably larger than 28 the S1 pockets, which allows for simultaneous binding of multiple LPS molecules (low-29 affinity, high-capacity" binding site). Thus, the S2 pocket could act as a "sink" for LPS upon 30 disaggregation, and the lower affinity promotes onward transfer to CD14 along the TLR4 relay. 31

Collectively, the S protein enhances the LPS transfer cascade by acting as an additional 32 delivery mediator to the LPS receptors. results, the cytokine production by these S protein reagents was abrogated by polymyxin B. 2

This further corroborates our proposed mechanism whereby the S protein is an intermediary 3 rather than a direct causality of hyperinflammation. It is worth noting that the S protein is not 4 the only SARS-CoV-2 protein associated with inflammatory responses; a recent study revealed 5 that the envelope (E) protein is recognised by the TLR2 receptor and induces the production of 6 inflammatory cytokines. 50 7

To date, around 2.7 million sequences of SARS-CoV-2 genome have been deposited 8 on the Global Initiative on Sharing All Influenza Data (GISAID) platform. 51 As SARS-CoV-2 9

is a rapidly mutating RNA virus, almost all of the residues on the S protein have been detected 10 to mutate at least once since its discovery in January 2020. 52 We calculated the percentage of 11 occurrence of amino acid changes from hydrophobic to non-hydrophobic residues for the LPS 12

binding residues and found a value of well below 0.01% for all positions in the three binding 13 pockets ( Figure 8A ). This indicates that the LPS binding residues are highly conserved in 14 emerging SARS-CoV-2 variants and are unlikely to mutate in the future. Hence, the LPS 15 binding pockets could be attractive targets for development of therapeutics. Interestingly, when 16 compared to sequences from other related beta-coronaviruses, most of these residues are also 17 conserved across different species (Figure 8B ), suggesting a potentially universal LPS binding 18 capability by these coronaviruses S proteins. We previously showed that the S protein from 19

SARS-CoV interacts with LPS similarly to the S protein from SARS-CoV-2; 19 further studies 20

would be required to determine LPS interactions with S proteins from other coronaviruses. 21

The binding of LPS to the NTD and RBD is interesting in itself due to the instrumental 22

role of these subdomains in immune evasion of the SARS-CoV-2. The binding of haem 23 metabolites to the NTD pocket has been shown to yield profound conformational changes 24

through an allosteric mechanism that inhibits neutralizing antibodies targeting the NTD 39 . As 25 LPS binds to the same pocket, it is possible that it could also alter the conformation of the 26 antigenic supersite found on the NTD 53 . In the RBD pocket, linoleic acid binding bridges two 27 adjacent RBDs 25 , hence favouring the RBD down state. Similarly, the charged headgroup of 28 LPS protrudes out of the binding cavity and could potentially interact with a neighbouring RBD 29

and shift the open-closed equilibrium of the S protein. The RBD is better shielded by glycans 30 in its down conformation 54 ; therefore, a shift towards the down state by LPS binding could 31 reduce accessibility to antibody epitopes and negatively impact neutralization. Various 32 mutations on the NTD and RBD found in SARS-CoV-2 variants promote accelerated 33 community transmission and vaccine breakthrough 55,56 . As described above, none of the 34 mutations recorded to date appear in any of the LPS binding pockets, implying that the S 35 proteins from these variants are competent to bind LPS. These mutations, along with the effect 36 of LPS binding on antibody epitopes, could therefore synergistically contribute towards 37 immune evasion. 38

The evolutionary origin of LPS binding capacity by the SARS-CoV-2 S protein remains 39 an enigma. From a structural standpoint, the presence of partially exposed hydrophobic patches 40 that allow for LPS binding is counterintuitive. It is worth noting that some of the residues in 41 the S2 pocket that we have shown interact with LPS acyl tails form the central core of the S 42 protein post-fusion structure 23 . That these residues become more exposed to solvent upon S1 43

shedding suggests that they may be a part of the "spring-loaded" S2 core that drives the pre-to 44 post-fusion conformational transition. The LPS binding site could therefore arise as a side 1 effect of the inclusion of these metastable features on the S protein structure required for its 2 function during viral infection. 3

The LPS binding sites could also have emerged to promote direct bacteria-virus 4

interaction. Interkingdom synergy between bacteria and viruses at the host-pathogen interface 5 plays monumental roles in various co-infections 57 . Direct interactions between enteric viruses 6 and bacteria through attachment to surface LPS improves viral host cell adherence and 7 environmental stability 58 , while promoting genetic recombination between viruses to restore 8 viral fitness 59 . Similarly, influenza virus interacts directly with the bacterial surface and 9

increases bacterial adherence to respiratory cells, worsening pathogenesis 60 . It is thus possible 10 that SARS-CoV-2 has evolved to bind Gram-negative bacteria via S protein-LPS interactions 11

to modulate certain aspects of its viral life cycle; however, the exact role of this interaction is 12

likely to be complex and would require further studies. 13

In conclusion, we report in detail the molecular mechanism of interaction between the 14 SARS-CoV-2 S protein and bacterial LPS, suggestive of how this interaction leads to enhanced 15 TLR4 mediated inflammatory responses. Our study also provides novel therapeutic avenues 16

for drug development against hyperinflammation observed in severe COVID-19 cases.

Acknowledgement 19

This work was supported by BII (A*STAR) core funds. P.J.B. and F.S. gratefully acknowledge 20 support from grant FY21_CF_HTPO SEED_ID_BII_C211418001 funded by A*STAR. 21

Simulations were performed using computational resources of the petascale computer cluster 22

ASPIRE-1 at the National Supercomputing Centre of Singapore (NSCC), the A*STAR 23

Computational to lower the pH to 2.5. Upon addition on quench buffer the reaction mixture was incubated on 1 ice for 1 min followed by online pepsin digestion.

Mass Spectrometry and peptide identification 4 ~100 pmol of quenched reaction mixture was injected onto the nanoUPLC HDX sample 5 manager (Waters, Milford, MA). Online pepsin digestion was performed on the injected 6 samples using immobilized Waters Enzymate BEH pepsin column (2.1 × 30 mm) at a flow rate 7

of 100 μl/min in 0.1% formic acid in water. Simultaneously, the pepsin proteolyzed peptides 8

were trapped in a 2.1 × 5 mm C18 trap (ACQUITY BEH C18 VanGuard Pre-column, 1.7 μm, 9

Waters, Milford, MA). Following pepsin digestion elution of proteolyzed peptide was carried 10 out using acetonitrile gradient of 8 to 40 % in 0.1 % formic acid at a flow rate of 40 µl min -1 11 into reverse phase column (ACQUITY UPLC BEH C18 Column, 1.0 × 100 mm, 1.7 μm, 12

Waters) pumped by nanoACQUITY Binary Solvent Manager (Waters, Milford, MA). 13

Resolved peptides were ionized using electrospray ionization mode and sprayed onto SYNAPT The purity of SARS-CoV-2 S, S1, S2 and S2 P-mutant subunits was evaluated by SDS-PAGE 36

( Supplementary Fig. S3 ). Briefly 2 µg of each protein was diluted in loading buffer and loaded 37 on 10-20% Novex Tricine pre-cast gel (Invitrogen, USA). The run was performed at 120 V for 38 1 h. The gel was stained by using Coomassie Brilliant blue (Invitrogen, USA). The image was 39 obtained using a Gel Doc Imager (Bio-Rad Laboratories, USA). 40

Two µg SARS-CoV-2 S1 or S2 subunit was incubated with 0.1, 0.25 or 0.5 mg/ml of E. coli Chemiluminescent Substrate (Thermo Scientific, Denmark) for 5 min followed by detection 2 using a ChemiDoc XRS Imager (Bio-Rad). LPS as well as lipid A were purchased from Sigma 3 (USA). In another set of experiments, 2 µg of S2 P-mutant was incubated with increasing doses 4 of E. coli LPS (0.1-0.5 mg/ml) for 30 min at 37 °C in 20 µl as final volume. At the end of 5

incubation samples were mixed with loading buffer and analysed as described above. All  6 experiments were performed at least 3 times. 7

Forty μg SARS-CoV-2 S, S1 or S2 protein were labelled by Monolith NT Protein labelling kit 9

RED -NHS (Nano Temper Technologies, Germany) according to the manufacturer's protocol. values ± SD of six measurements.

Unbiased molecular dynamics simulations 18

All-atom MD simulations were performed to elucidate lipid A/LPS binding mechanism to the 19 pockets on S1 and S2 subunits of the S protein. For the S1 pockets, a hexa-acylated E. coli lipid 20

A molecule was placed 3 nm away from the S protein NTD (residue 14-305) and RBD (residue 21 335-525) facing the polysorbate and linoleic acid binding sites, 25,61 respectively. For the S2 22

pocket, we performed simulations of E. coli LPS bound to the pocket with S1 subunit (residue 23 14-685) and S2 subunit (686-1162) independently. Additionally, we ran simulations of 24 multiple lipid A binding, whereby three lipid A molecules were placed outside of the inter-25

protomeric groove near the S1/S2 cleavage site at a center of mass distance of at least 2 nm 26 away from the bound lipid A. The initial coordinates of E. coli lipid A and LPS were obtained 27 from CHARMM-GUI LPS modeller, 62 while the initial coordinates of the S protein were 28 extracted from the cryo-EM structure of S ECD in the closed state (PDB: 6XR8) 23 with missing 29 loops constructed using Modeller version 9.21. 63 Protein and lipid were parameterized using 30 the CHARMM36 forcefield. 64 The systems were solvated with TIP3P water molecules and 31 0.15 M NaCl salts. Steepest descent minimisation and a short 125 ps equilibration simulation 32

were performed, following the standard CHARMM-GUI protocols. 65 Three replicates of 1 µs 33 simulations were performed for each of the S1 pockets, while three replicates of 500 ns 34 simulations were performed for the S2 pocket, with different initial velocities. Coupling to a 35

Nosé-Hoover thermostat 66,67 was used to maintain a temperature of 310 K, whilst isotropic 36 coupling to a Parrinello-Rahman barostat 68 was used to maintain a 1 atm pressure. Coulombic 37

interactions were computed using the smooth particle mesh Ewald (PME) method 69 , and the 38 van der Waals interactions were truncated at 1.2 nm with a force smoothing function applied 39 between 1.0 to 1.2 nm. A 2-fs time step was used with constraints applied on all covalent bonds 40

involving hydrogen atoms using the LINCS algorithm. 70 All simulations were performed using 41

GROMACS 2018 71 and the trajectories visualised in VMD. 72 Most analyses were performed 42 using GROMACS tools, while the pocket volume was calculated using MDPocket. 73 43 44

To estimate the binding affinity of lipid A to each binding site on the S protein, PMF 2 calculations were performed along a reaction coordinate parallel to the lipid dissociation 3 pathway from the binding pockets. For the S2 binding site, the docked lipid A complex 19 was 4 used as starting coordinates. For the NTD and RBD binding sites, cluster analysis was 5

performed on the unbiased simulations described above, and the central structures of the top 6 clusters were used. Steered MD simulations were first performed to generate the trajectories of 7 lipid dissociation. Lipid A was pulled away from the binding pockets along an axis 8 perpendicular to the protein surface at a constant velocity of 0.1 nm ns -1 using an elastic spring 9

with a force constant of 1,000 kJ mol -1 nm 2 applied to its centre of mass. Positional restraints 10 with a force constant of 1,000 kJ mol -1 nm 2 were applied to the backbone atoms of the protein 11 throughout. From these trajectories, 50 umbrella sampling windows were selected based on the 12 distance between the centers of mass of the lipid and protein along the reaction coordinate with 13 a separation of 0.1 nm between windows. Subsequently, a 100 ns simulation was performed 14

for each window with the centre of mass of lipid A restrained in the vector of the reaction 15 coordinate with a force constant of 1,000 kJ mol -1 nm 2 . No restraint was applied to the protein.

The GROMACS gmx wham tool based on the weighted histogram analysis method (WHAM) 74 17 was used to compute the PMF from the umbrella sampling simulations. Histogram overlaps 18

were plotted to determine any poor sampling along the reaction coordinate, for which 19 additional simulations were performed. 100 bootstrap trials were performed for each PMF 20 calculation to estimate the statistical errors. Convergence analysis was performed by generating 21

PMF profiles using increasing amounts of simulation sampling time. BlueTM, InvivoGen), followed by absorbance measurement at 600 nm. In another set of 32 experiments, cells were treated with 5 nM SARS-CoV-2 S1 and S2 protein in the presence of 33 0.25 ng/ml LPS and 100 μg/ml polymyxin B. The experiment was performed as described 34

above. Data shown are mean values ± SD obtained from at least four independent experiments 35 all performed in triplicate. 36

The viability of cells exposed to different treatments was evaluated by adding 0.5 mM 38

Thiazolyl Blue Tetrazolium Bromide (MTT) to the cells remaining from NF-κB activation 39 assay and incubating the cells at 37 °C for 2 h. Next, cells were centrifuged at 1000 g for 5 min 12 weeks old) were used to study the immunomodulatory effects of SARS-CoV-2 S protein 5

subunits alone or in combination with LPS. Using a trimmer, hair was removed from the 6 dorsum of the mouse and cleaned. Five µg of S1 or S2 protein was mixed with 2 µg LPS 7

immediately before subcutaneous deposition. Mice were anesthetized with isoflurane (Baxter, 8

Deerfield, IL, USA) and preparations were injected subcutaneously either in the left or the right 9

side of the dorsum. In one group of animals, to study the effect of polymyxin B on S2-induced 10 NF-kB activation, 5 µg of S2 was mixed with 1 mg of polymyxin B (Sigma) immediately 11 before subcutaneous deposition. Animals were then immediately transferred to individually 12 ventilated cages. An In Vivo Imaging System (IVIS Spectrum, PerkinElmer Life Sciences) was 13 used for the longitudinal imaging of NF-κB activation. Mice were imaged at 1, 3, and 6 h after 14 the subcutaneous deposition. Fifteen minutes before the IVIS imaging, mice were 15

intraperitoneally given 100 µl of D-luciferin (150 mg/kg body weight). Bioluminescence 16 signals from the mice were detected and quantified using Living Image 4.0 Software 17 (PerkinElmer Life Sciences). 18

The data supporting the findings of the study are available in the article and its Supporting 20

Information or available upon request from the corresponding authors. protein: lipid A state and free S protein state at deuterium labelling times t = 1 and 10 min . 5

Pepsin proteolyzed peptide fragments are grouped according to the S protein domain 6 organisation from N to C-termini and plotted along X-axis and its corresponding difference in 7

deuterium exchange values (∆Dex) along Y-axis. A difference cut-off of ±0.5 Da is 8 the significance threshold indicated with red dotted line. (B) Differences in deuterium 9 exchange values at labelling times 1 and 10 min for S protein domains NTD (i), RBD (ii) and 10 S2 domain (iii) are mapped on to the respective structures (C) Differences in deuterium 11 exchange values at labelling times t= 1 min and 10 min are mapped on to the full-length S 12 protein (14-1208) structure. Deuterium exchange differences are colour coded as per key. 13 14 Figure 2 : Analysis of binding of S1 and S2 subunits to LPS and lipid A. SARS-CoV-2 S 15 protein or its subunits, S1 and S2, were incubated with (0-500 µg/ml) LPS (A) or lipid A (B), 16 separated using BN-PAGE and detected by western blotting. One representative image of three 17 independent experiments is shown (n=3). The intensity of the bands at 480, 242 and 146 kDa, 18

corresponding to molecular mass of monomeric SARS-CoV-2 S protein or S1 and S2 subunits, 19

respectively, were quantified using Image Lab software 6.1 from Bio-Rad. and D) Percentage of lipid tail atoms exposed to solvent. Solvent exposed atoms are defined as shown in cyan cartoon representation, while lipid A is shown in orange stick representation.

The reaction coordinate is the distance between the centers of mass of lipid A and the protein.

Shaded areas indicate standard deviations estimated using bootstrapping. (B and C) Similar 43 PMF calculations for lipid A at the NTD pocket and the S2 pocket, respectively. (D) The 44 binding affinity of LPS to S1 and S2 subunits of S protein was quantified by microscale 1 thermophoresis. Representative binding curves are shown on the left, while KD constant 2 obtained from the curves are summarized with the histograms on the right. KD for S protein is 3 46.7 ± 19.7 nM, for S1 subunit 50.0 ± 20.0 nM and for S2 3.6 ± 1.6 µM. Data are shown as 4 mean ± SD (n=6). reporter mice. In vivo imaging of NF-κB reporter gene expression was performed using the 24 IVIS Spectrum system. Representative images show bioluminescence at 1, 3 and 6 h after 25 subcutaneous deposition and bar charts show bioluminescence emitted from these reporter 26 mice. Areas of subcutaneous deposition and region of interest for data analysis are depicted as 27 dotted circles. Data are presented as the mean ± SEM (n = 4). P values were determined using 28 a one-way ANOVA with Dunnett posttest. *P £ 0.05; **P £ 0.01; ***P £ 0.001; ****P £ 29 0.0001; ns, not significant. 30 31 Figure 7 : Proposed model for S protein boosting effect on LPS-mediated 32 proinflammatory response. In the presence of S protein, LPS micelles disaggregate due to 33 binding to high-affinity, low-capacity sites on the S1 subunit. These binding pockets have 34 similar affinities to CD14, resulting in unfavourable onward transfer. However, the presence 35

of proteases in vivo that may compromise LPS binding, as well as endogenous hydrophobic 36 molecules such as lipids and metabolites that may displace bound LPS, result in transfer to 37

CD14. Free LPS molecules can also bind to the S2 subunit, whose low-affinity, high-capacity 38

binding pocket can accommodate more than one LPS molecule simultaneously. The lower 39

binding affinity would also facilitate downstream LPS transfer to CD14. Subsequently, LPS is 40 transferred to the TLR4:MD-2 complex, which triggers proinflammatory reactions. Thus, the 41 S protein acts as an intermediate in the LPS receptor transfer cascade. 42 deposited in the GISAID initiative database. 3 The percentages for all mutations are shown in 3 grey, while the percentages for mutations on residues predicted to be involved in LPS binding 4

to non-hydrophobic residues are shown in blue (NTD pocket), red (RBD pocket) and green (S2 5 pocket). The latter occur at well below 0.01% in all reported sequences to date. Data was taken 6

in August 2021 when 2,701,750 sequences had been reported. (B) Multiple sequence alignment 7

of SARS-CoV-2 S protein with S proteins from other beta-coronaviruses showing conservation 8 of predicted LPS binding residues. Residues that are more than 30% conserved are shaded in 9

blue, while similar residues are shaded in red. LPS binding residues from the NTD, RBD and 10 S2 pockets are highlighted by the blue, red and green circles, respectively. S proteins from 11 different species of coronaviruses with at least 30% sequence identity to SARS-CoV-2 S were 12 selected. UniProt IDs: SARS-CoV-2, P0DTC2; Bat-CoV, Q3LZX1; SARS-CoV, P59594; 13 MERS-CoV, K9N5Q8; Murine-CoV, P11224; Bovine-CoV, P25191; HCoV-OC43, P36334; 14

HCoV-HKU1, Q5MQD0. 15

the severity of COVID-19 outcomes

Senolytics reduce coronavirus-related mortality in old mice. 2 Science (80-. )

Lipopolysaccharide is in close proximity to each of the proteins in its membrane 5 receptor complex. Transfer from CD14 to TLR4 and MD-2

Lipopolysaccharide recognition: CD14, TLRs and 8 the LPS-activation cluster

Reconstruction of LPS Transfer Cascade Reveals Structural 10 Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and 11 Transfer

SARS-CoV-2 spike protein interacts with and activates TLR41

SARS-CoV-2 Spike S1 glycoprotein 15 is a TLR4 agonist , upregulates ACE2 expression and induces pro-inflammatory M 1 16 macrophage polarisation

TLR2 senses the SARS-CoV-2 envelope protein to produce 18 inflammatory cytokines

Data, disease and diplomacy: GISAID's innovative 20 contribution to global health

N-terminal domain antigenic mapping reveals a site of 24 vulnerability for SARS-CoV-2

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike 26 Protein

Antigenic minimalism of SARS-CoV-2 is linked to 28 surges in COVID-19 community transmission and vaccine breakthrough infections

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of 31 concern

Bacterial lipopolysaccharide 35 binding enhances virion stability and promotes environmental fitness of an enteric 36 virus

Bacteria Facilitate Enteric Virus Co-infection of Mammalian 38 Cells and Promote Genetic Recombination

Direct interactions with influenza promote bacterial adherence 40 during respiratory infections

Structural analysis of full-length SARS-CoV-2 spike protein from an 42 advanced vaccine candidate

CHARMM-GUI Membrane Builder for Complex Biological Membrane 45 Simulations with Glycolipids and Lipoglycans

Comparative protein modelling by satisfaction of spatial 48 restraints

CHARMM36 all-atom additive protein force field: 50 Validation based on comparison to NMR data

CHARMM-GUI Input Generator for NAMD

Simulations Using the CHARMM36 Additive 4 Force Field

A molecular dynamics method for simulations in the canonical ensemble

Canonical dynamics: Equilibrium phase-space distributions

Polymorphic Transitions in Single Crystals: a New 10 Molecular Dynamics Method

A smooth particle mesh Ewald method

LINCS: A linear 14 constraint solver for molecular simulations

Gromacs: High performance molecular simulations through 16 multi-level parallelism from laptops to supercomputers

VMD: Visual Molecular Dynamics

MDpocket: Open-source 20 cavity detection and characterization on molecular dynamics trajectories

THE 23 weighted histogram analysis method for free-energy calculations on biomolecules. I. 24 The method